Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.
about
CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.Pros and cons of liver transplantation in human immunodeficiency virus infected recipients.Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityLiver transplantation in HCV/HIV positive patients.Virological efficacy and immunological recovery among Ethiopian HIV-1 infected adults and children.New challenges in therapeutic vaccines against HIV infection.Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection.Anti-proliferative therapy for HIV cure: a compound interest approach.A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil.Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada.Liver transplantation for HIV/hepatitis C virus co-infected patients.Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK.US cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, HIV-infected adults with evidence of protease inhibitor resistance included in the TITAN Trial.Cost effectiveness of darunavir/ritonavir 600/100 mg bid in protease inhibitor-experienced, HIV-1-infected adults in Belgium, Italy, Sweden and the UK.Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA.Mycophenolate: dual utility in rare conditions of HIV infection complicating lupus.A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
P2860
Q33237178-0A9B38FA-BAD3-4AF0-84A2-E2424F414371Q33594879-6D5326FA-82EB-489E-A501-38E1CCFFF29DQ33781206-5EF59652-F6AF-4B55-9BD9-14A529ACF014Q34640985-327DBC84-C81F-4581-B906-FC42DD9A5B54Q37509894-034C647D-87E0-4B71-A769-78199BC5C324Q38692205-12A395D8-565B-432F-B7E6-2EEA8F9C1A50Q39226064-B46F77B5-351D-4AE2-9F9C-111F8D38B2DEQ40150493-7343814E-C55B-4D5B-87A7-4882C0C9F0E8Q41857320-8FA77466-5EE2-4C07-AAFC-AB6328B7AF6DQ42213902-0D997ACA-0151-4D8F-B11D-EAE7BEBAB29FQ42265713-42294ABA-5D21-40EF-9092-70D170ED9843Q42772430-6AD879E1-3127-45F2-9692-1E668529D81FQ42772433-98A70DCC-FECE-4987-B7A1-2055E07ABC3AQ42772436-F10E4CB1-5047-4033-9CC8-C985E6D2547CQ42772440-F21282D6-9F85-4B18-8E0B-0B31521E6441Q43161427-88A14204-F6DA-4951-9438-4C18B5DC190DQ59136614-B7C8793A-1D5A-4093-9DBF-C3385A61336B
P2860
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Effect of mycophenolate mofeti ...... ion: a randomized pilot study.
@en
type
label
Effect of mycophenolate mofeti ...... ion: a randomized pilot study.
@en
prefLabel
Effect of mycophenolate mofeti ...... ion: a randomized pilot study.
@en
P2093
P50
P1476
Effect of mycophenolate mofeti ...... tion: a randomized pilot study
@en
P2093
Anna López
Cristina Gil
Elena Vidal
Emilio Fumero
Jaume Martorell
José M Gatell
José M Miró
Mireia Arnedo
Montserrat Plana
Olga Millán
P304
P356
10.1097/00126334-200407010-00009
P407
P577
2004-07-01T00:00:00Z